Optical imaging of Cerenkov light generation from positron-emitting radiotracers

Radiotracers labeled with high-energy positron emitters, such as those commonly used for positron emission tomography studies, emit visible light immediately following decay in a medium. This phenomenon, not previously described for these imaging tracers, is consistent with Cerenkov radiation and has several potential applications, especially for in vivo molecular imaging studies. Herein we detail a new molecular imaging tool, Cerenkov Luminescence Imaging, the experiments conducted that support our interpretation of the source of the signal, and proof-of-concept in vivo studies that set the foundation for future application of this new method.

[1]  Rebecca Richards-Kortum,et al.  Optical contrast agents and imaging systems for detection and diagnosis of cancer , 2008, International journal of cancer.

[2]  R. Weissleder,et al.  Imaging in the era of molecular oncology , 2008, Nature.

[3]  M. Rolfe,et al.  Longitudinally Quantitative 2-Deoxy-2-[18F]fluoro-d-glucose Micro Positron Emission Tomography Imaging for Efficacy of New Anticancer Drugs: A Case Study with Bortezomib in Prostate Cancer Murine Model , 2006, Molecular Imaging and Biology.

[4]  Joel Karp,et al.  Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[5]  M. O'Doherty,et al.  FDG-PET after two to three cycles of chemotherapy predicts progression-free and overall survival in high-grade non-Hodgkin lymphoma. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

[6]  Bruce D Cheson,et al.  Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development , 2005, Clinical Cancer Research.

[7]  Michael F. L'Annunziata,et al.  Handbook of Radioactivity Analysis , 2003 .

[8]  R L Wahl,et al.  Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose: variations with body weight and a method for correction. , 1993, Radiology.

[9]  L P Clarke,et al.  Bremsstrahlung imaging using the gamma camera: factors affecting attenuation. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[10]  H. Ross Measurement of .beta.-emitting nuclides using Cerenkov radiation , 1969 .

[11]  R. P. Parker,et al.  The use of Cerenkov radiation in the measurement of β-emitting radionuclides , 1968 .

[12]  R. P. Parker,et al.  The use of Cerenkov radiation in the measurement of beta-emitting radionuclides. , 1968, The International journal of applied radiation and isotopes.

[13]  O. Warburg [Origin of cancer cells]. , 1956, Oncologia.

[14]  S. Brown,et al.  Cerenkov radiation and its applications , 1955 .

[15]  L. M. Tolman,et al.  ESTIMATION OF SUGARS BY MEANS OF THE REFRACTOMETER. , 1906 .